135 related articles for article (PubMed ID: 34423983)
1. Design, Synthesis, and Evaluation of [
Matsuda S; Hattori Y; Matsumiya K; McQuade P; Yamashita T; Aida J; Sandiego CM; Gouasmat A; Carroll VM; Barret O; Tamagnan G; Koike T; Kimura H
J Med Chem; 2021 Sep; 64(17):12680-12690. PubMed ID: 34423983
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, and Evaluation of (2-Aminocyclopropyl)phenyl Derivatives as Novel Positron Emission Tomography Imaging Agents for Lysine-Specific Demethylase 1 in the Brain.
Hattori Y; Matsuda S; Baba R; Matsumiya K; Iwasaki S; Constantinescu CC; Morley TJ; Carroll VM; Papin C; Gouasmat A; Alagille D; Tamagnan G; Koike T
J Med Chem; 2021 Apr; 64(7):3780-3793. PubMed ID: 33729758
[TBL] [Abstract][Full Text] [Related]
3. Mining the Dynamical Properties of Substrate and FAD Binding Pockets of LSD1: Hints for New Inhibitor Design Direction.
Yang K; Liu H
J Chem Inf Model; 2024 Jun; 64(12):4773-4780. PubMed ID: 38837697
[TBL] [Abstract][Full Text] [Related]
4. T-448, a specific inhibitor of LSD1 enzyme activity, improves learning function without causing thrombocytopenia in mice.
Matsuda S; Baba R; Oki H; Morimoto S; Toyofuku M; Igaki S; Kamada Y; Iwasaki S; Matsumiya K; Hibino R; Kamada H; Hirakawa T; Iwatani M; Tsuchida K; Hara R; Ito M; Kimura H
Neuropsychopharmacology; 2019 Jul; 44(8):1505-1512. PubMed ID: 30580376
[TBL] [Abstract][Full Text] [Related]
5. Lysine-specific histone demethylase 1 (LSD1): A potential molecular target for tumor therapy.
Chen Y; Jie W; Yan W; Zhou K; Xiao Y
Crit Rev Eukaryot Gene Expr; 2012; 22(1):53-9. PubMed ID: 22339659
[TBL] [Abstract][Full Text] [Related]
6. Lysine-specific demethylase 1-mediated demethylation of histone H3 lysine 9 contributes to interleukin 1β-induced microsomal prostaglandin E synthase 1 expression in human osteoarthritic chondrocytes.
El Mansouri FE; Nebbaki SS; Kapoor M; Afif H; Martel-Pelletier J; Pelletier JP; Benderdour M; Fahmi H
Arthritis Res Ther; 2014 May; 16(3):R113. PubMed ID: 24886859
[TBL] [Abstract][Full Text] [Related]
7. Drug Design Concepts for LSD1-Selective Inhibitors.
Ota Y; Suzuki T
Chem Rec; 2018 Dec; 18(12):1782-1791. PubMed ID: 30277644
[TBL] [Abstract][Full Text] [Related]
8. Identifying the novel inhibitors of lysine-specific demethylase 1 (LSD1) combining pharmacophore-based and structure-based virtual screening.
Sun XD; Zheng YC; Ma CY; Yang J; Gao QB; Yan Y; Wang ZZ; Li W; Zhao W; Liu HM; Ding L
J Biomol Struct Dyn; 2019 Oct; 37(16):4200-4214. PubMed ID: 30366512
[TBL] [Abstract][Full Text] [Related]
9. Nucleosome Binding by the Lysine Specific Demethylase 1 (LSD1) Enzyme Enables Histone H3 Demethylation.
Dhall A; Shelton PMM; Delachat AM; Leonen CJA; Fierz B; Chatterjee C
Biochemistry; 2020 Jul; 59(27):2479-2483. PubMed ID: 32567837
[TBL] [Abstract][Full Text] [Related]
10. Structural insight into inhibitors of flavin adenine dinucleotide-dependent lysine demethylases.
Niwa H; Umehara T
Epigenetics; 2017 May; 12(5):340-352. PubMed ID: 28277979
[TBL] [Abstract][Full Text] [Related]
11. A Systematic Review of Histone Lysine-Specific Demethylase 1 and Its Inhibitors.
Zheng YC; Ma J; Wang Z; Li J; Jiang B; Zhou W; Shi X; Wang X; Zhao W; Liu HM
Med Res Rev; 2015 Sep; 35(5):1032-71. PubMed ID: 25990136
[TBL] [Abstract][Full Text] [Related]
12. Catalytic mechanism investigation of lysine-specific demethylase 1 (LSD1): a computational study.
Kong X; Ouyang S; Liang Z; Lu J; Chen L; Shen B; Li D; Zheng M; Li KK; Luo C; Jiang H
PLoS One; 2011; 6(9):e25444. PubMed ID: 21984927
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, and In Vitro Evaluation of Novel Histone H3 Peptide-Based LSD1 Inactivators Incorporating α,α-Disubstituted Amino Acids with γ-Turn-Inducing Structures.
Ota Y; Kakizawa T; Itoh Y; Suzuki T
Molecules; 2018 May; 23(5):. PubMed ID: 29734782
[TBL] [Abstract][Full Text] [Related]
14. Structural insights into histone lysine demethylation.
Hou H; Yu H
Curr Opin Struct Biol; 2010 Dec; 20(6):739-48. PubMed ID: 20970991
[TBL] [Abstract][Full Text] [Related]
15. [Histone demethylase LSD1 and its biological functions].
Shao GB; Huang XJ; Gong AH; Zhang ZJ; Lu RZ; Sang JR
Yi Chuan; 2010 Apr; 32(4):331-8. PubMed ID: 20423886
[TBL] [Abstract][Full Text] [Related]
16. Lysine-specific demethylase-1 contributes to malignant behavior by regulation of invasive activity and metabolic shift in esophageal cancer.
Kosumi K; Baba Y; Sakamoto A; Ishimoto T; Harada K; Nakamura K; Kurashige J; Hiyoshi Y; Iwatsuki M; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Oki E; Watanabe M; Hino S; Nakao M; Baba H
Int J Cancer; 2016 Jan; 138(2):428-39. PubMed ID: 26240060
[TBL] [Abstract][Full Text] [Related]
17. Development and Structural Evaluation of N-Alkylated trans-2-Phenylcyclopropylamine-Based LSD1 Inhibitors.
Niwa H; Sato S; Handa N; Sengoku T; Umehara T; Yokoyama S
ChemMedChem; 2020 May; 15(9):787-793. PubMed ID: 32166890
[TBL] [Abstract][Full Text] [Related]
18. Discovery of resveratrol derivatives as novel LSD1 inhibitors: Design, synthesis and their biological evaluation.
Duan YC; Guan YY; Zhai XY; Ding LN; Qin WP; Shen DD; Liu XQ; Sun XD; Zheng YC; Liu HM
Eur J Med Chem; 2017 Jan; 126():246-258. PubMed ID: 27888721
[TBL] [Abstract][Full Text] [Related]
19. Nonpeptidic propargylamines as inhibitors of lysine specific demethylase 1 (LSD1) with cellular activity.
Schmitt ML; Hauser AT; Carlino L; Pippel M; Schulz-Fincke J; Metzger E; Willmann D; Yiu T; Barton M; Schüle R; Sippl W; Jung M
J Med Chem; 2013 Sep; 56(18):7334-42. PubMed ID: 24007511
[TBL] [Abstract][Full Text] [Related]
20. Expression, Purification, and Biochemical Analysis of the LSD1/KDM1A Histone Demethylase.
Laurent B; Shi Y
Methods Enzymol; 2016; 573():241-59. PubMed ID: 27372756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
